Liver metastases: The role of magnetic resonance imaging

World J Gastroenterol. 2023 Sep 28;29(36):5180-5197. doi: 10.3748/wjg.v29.i36.5180.

Abstract

The liver is one of the organs most commonly involved in metastatic disease, especially due to its unique vascularization. It's well known that liver metastases represent the most common hepatic malignant tumors. From a practical point of view, it's of utmost importance to evaluate the presence of liver metastases when staging oncologic patients, to select the best treatment possible, and finally to predict the overall prognosis. In the past few years, imaging techniques have gained a central role in identifying liver metastases, thanks to ultrasonography, contrast-enhanced computed tomography (CT), and magnetic resonance imaging (MRI). All these techniques, especially CT and MRI, can be considered the non-invasive reference standard techniques for the assessment of liver involvement by metastases. On the other hand, the liver can be affected by different focal lesions, sometimes benign, and sometimes malignant. On these bases, radiologists should face the differential diagnosis between benign and secondary lesions to correctly allocate patients to the best management. Considering the above-mentioned principles, it's extremely important to underline and refresh the broad spectrum of liver metastases features that can occur in everyday clinical practice. This review aims to summarize the most common imaging features of liver metastases, with a special focus on typical and atypical appearance, by using MRI.

Keywords: Gadolinium; Gadoxetate disodium; Gd-EOB-DTPA; Hepatobiliary contrast agents; Liver metastases; Liver specific contrast agents; Magnetic resonance imaging.

Publication types

  • Review

MeSH terms

  • Contrast Media*
  • Gadolinium DTPA
  • Humans
  • Liver / diagnostic imaging
  • Liver / pathology
  • Liver Neoplasms* / pathology
  • Magnetic Resonance Imaging / methods

Substances

  • Contrast Media
  • Gadolinium DTPA